Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Cash Flows

v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Oct. 31, 2025
Oct. 31, 2024
Net income $ 6,373 $ 16,207
Adjustments to reconcile net income to net cash provided by operating activities:    
Non-cash operating lease expense 5,265 5,103
Foreign currency adjustments 0 (1,234)
Depreciation 41,706 41,969
Deferred income taxes 2,518 5,281
Amortization of deferred financing costs 1,729 1,803
Amortization of intangible assets 11,837 15,141
Stock-based compensation expense 2,048 2,394
Change in fair value of warrant liabilities (0) (130)
Loss on extinguishment of debt 1,392 0
Net gain on the sale of property, plant and equipment (1,025) (2,309)
Other operating activities (272) (78)
Net changes in operating assets and liabilities:    
Receivables 3,539 7,164
Inventory (1,204) 600
Other operating assets (3,448) 632
Accounts payable (1,522) (1,679)
Other operating liabilities (4,621) (3,964)
Net cash provided by operating activities 64,315 86,900
Cash flows from investing activities:    
Purchases of property, plant and equipment (46,787) (43,810)
Proceeds from sale of property, plant and equipment 9,492 11,679
Net cash used in investing activities (37,295) (32,131)
Cash flows from financing activities:    
Proceeds on long term debt 425,000 0
Payments on long term debt (375,000) 0
Proceeds on revolving loan 256,233 313,170
Payments on revolving loan (256,254) (332,104)
Dividends paid (53,132) 0
Payment of debt issuance costs (8,163) (953)
Purchase of treasury stock (14,167) (10,160)
Other financing activities (274) 1,279
Net cash used in financing activities (25,757) (28,768)
Net increase in cash and cash equivalents 1,353 27,180
Effect of foreign currency exchange rate changes on cash 90 1,179
Cash and cash equivalents:    
Beginning of period 43,041 15,861
End of period $ 44,394 $ 43,041